Skip to main content

Closed

NRXP: NRx Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

45thpctl

Volume

0.94×avg

Market Cap

54.45MUSD

P/E Ratio

-2.5TTM

Div Yield

-ann

NRx Pharmaceuticals, Inc.

NRXPNASDAQ Global Market·USD·Closed

NRx Pharmaceuticals, Inc.

NRXPNASDAQ·USD·Closed

$3.15

+0.96%

$3.15

+$0.03 (0.96%)

52W Range

45thpctl

Volume

0.94×avg

Mkt Cap

54.45MUSD

P/E

-2.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings